AdaptHealth has seen its share price move around in recent years, which puts a spotlight on a basic question for anyone looking at the stock today. Is the current valuation that the market is placing on AdaptHealth really supported by what the business is generating in sales. Over the past 5 years the stock has fallen 65.8%, so any decision today leans heavily on whether the underlying revenue base can carry the current market value. The business model relies on turning recurring equipment...
AdaptHealth reported third quarter 2026 sales of US$745.65 million and a net loss of US$153.99 million. The loss was driven in part by a US$184.75 million goodwill impairment. The company then slightly raised full year net revenue guidance to a range of US$2.88 billion to US$2.90 billion. The combination of a sizeable impairment and widened losses with a higher revenue outlook highlights how AdaptHealth is absorbing past balance sheet hits while still signaling confidence in ongoing demand...
AdaptHealth (AHCO) is back in focus after a packed early November. The business reported a large third quarter goodwill impairment, raised full year 2026 revenue guidance, and posted fresh quarterly results that reshaped the recent story. Recent trading suggests investors are reassessing AdaptHealth. The 30 day share price return of 27.39% and 90 day gain of 33.80% come after a year to date share price decline of 20.17% and a 1 year total shareholder return fall of 19.08%, as the goodwill...
AdaptHealth Corp (AHCO) posted 10.9% revenue growth and raised full-year guidance, but a $184.8 million non-cash goodwill impairment drove a GAAP net loss and free cash flow guidance was lowered.
AdaptHealth (NASDAQ:AHCO) reported third-quarter results that exceeded its revenue and adjusted EBITDA guidance, citing improving performance in its largest capitated contract, continued organic growth in its base business and tighter cost controls. Chief Executive Officer Suzanne Foster said the q
PLYMOUTH MEETING, Pa., September 11, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences:
Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.
Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) fell 8.6% in the afternoon session after the company announced the appointment of Harriss T. Currie as Chief Financial Officer, taking over duties from Jason Clemens.
Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.
AdaptHealth (AHCO) said late Tuesday it has appointed Harriss Currie as chief financial officer, eff
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q2.
Detailed price information for Adapthealth Corp Cl. A (AHCO-Q) from The Globe and Mail including charting and trades.
Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.